Bitterfeld - Wolfen, Germany
Bitterfeld - Wolfen, Germany

Hanwha Q CELLS is a manufacturer of photovoltaic cells. The company is headquartered in Thalheim, Germany. The company was established in 1999 as Q-Cells AG. Since 2012 it is a part of the Hanwha Group.The company develops and produces crystalline silicon photovoltaic cells. It has the cell production sites in Malaysia and Germany and the module production line in Germany. Its two most important markets are Europe and Japan. Wikipedia.


Time filter

Source Type

Grant
Agency: European Commission | Branch: FP7 | Program: CP | Phase: ENERGY.2010.2.1-1 | Award Amount: 7.02M | Year: 2010

The overall objective of the current project is a significant contribution to the dissemination of PV in order to improve the sustainability of the European energy supply and to strengthen the situation of the European PV industry. The approach to reach this overall objective is the development of solar cells which are substantially thinner than todays common practice. We will reduce the current solar cell thickness of typically 180 m down to a minimum of 50 m. At the same time we target to produce solar cells with high efficiencies in the range of 20% light conversion rate into power. The processes will be optimized and transferred into a pilot production line aiming at an efficiency of 19.5% on wafers of 100 m thickness at a yield that is comparable to the one in standard production lines. This shall help to drive down production costs significantly and save Si resources from todays 8 grams per watt to 3 grams per watt. In more detail the following topics are addressed: Wafering from Si ingots, surface passivation, light trapping, solar cell and module processing and handling of the thin wafers The partners of this project form an outstanding consortium to reach the project goals, including four leading European R&D institutes as well as four companies with recorded and published expertise in the field of thin solar cells and modules and handling of such. The project is structured in 10 work packages covering the process chain from wafer to module and the transfer into pilot production already at mid term as well as integral eco-assessment and management tasks.


Patent
Q - Cells SE | Date: 2015-04-14

A semiconductor device, in particular a solar cell, comprises a semiconductor substrate having a semiconductor substrate surface and a passivation composed of at least one passivation layer which surface-passivates the semiconductor substrate surface, wherein the passivation layer comprises a compound composed of aluminium oxide, aluminium nitride or aluminium oxynitride and at least one further element.


The objects of the present invention are: to provide a therapeutic agent and a therapeutic method for periodontal diseases and pulpal diseases, a transplant for periodontal tissue regeneration, and a method for regenerating the periodontal tissue. According to the present invention, there are provided therapeutic agents for periodontal diseases and pulpal diseases which comprise neurotrophic factors as an active ingredient.


A method according to the present invention for producing a cartilage-damage treatment agent, includes the steps of: (i) proliferating mesenchymal stem cells in a serum-free medium A containing an FGF, a PDGF, a TGF-, an HGF, an EGF, at least one phospholipid and at least one fatty acid; and (ii) mixing the mesenchymal stem cells thus proliferated in the step (i), an isotonic preserving agent, and a cytoprotective agent. This method provides a cartilage-damage treatment agent which favorably regenerates a cartilage tissue.


Disclosed are: a culture medium containing a specific growth factor and at least one phospholipid; a composition for preparation of the culture medium; a kit; and a method. A technique can be provided which uses a serum-free or low-serum culture medium and has a promoting effect on the proliferation of an animal cell comparable to the promoting effect obtained by the culture in a serum-containing culture medium.


A method according to the present invention for producing a cartilage-damage treatment agent, includes the steps of: (i) proliferating mesenchymal stem cells in a serum-free medium A containing an FGF, a PDGF, a TGF-, an HGF, an EGF, at least one phospholipid and at least one fatty acid; and (ii) mixing the mesenchymal stem cells thus proliferated in the step (i), an isotonic preserving agent, and a cytoprotective agent. This method provides a cartilage-damage treatment agent which favorably regenerates a cartilage tissue.


A cell preparation containing mesenchymal stem cells whose immunosuppression ability is maintained is produced by means of a serum-free or low-serum culture. A method for producing a cell preparation containing mesenchymal stem cells, comprising the steps of: (A) proliferating mesenchymal stem cells in a serum-free medium A containing an FGF, a PDGF, a TGF-, an HGF, an EGF, at least one phospholipid, and at least one fatty acid; and (B) screening mesenchymal stem cells whose immunosuppression ability is maintained or improved, from the mesenchymal stem cells thus proliferated in the step (A).


Patent
Hidemi Kurihara and Q - Cells SE | Date: 2012-03-05

The objects of the present invention are: to provide a therapeutic agent and a therapeutic method for periodontal diseases and pulpal diseases, a transplant for periodontal tissue regeneration, and a method for regenerating the periodontal tissue.


Patent
Q - Cells SE | Date: 2016-05-26

The present invention can be used for actual implantation surgery without a scaffold. The present invention provides a synthetic tissue or complex which can be produced by culture and has a high level of differentiation ability. The present invention also provides a therapy and medicament for repairing and/or regenerating tissue using replacement and covering. By culturing cells under specific culture conditions such that medium contains an extracellular matrix synthesis promoting agent, the cells are organized and are easily detached from a culture dish. The present invention was achieved by finding such a phenomenon. In addition, the self contraction of the tissue can be regulated by culturing the tissue in a suspended manner. Therefore, it is possible to regulate the three-dimensional shape of the tissue. The present invention also provides a method for producing an implantable synthetic tissue which does not require a plurality of monolayer cell sheets assembled to form a three-dimensionally structured synthetic tissue. The present invention is characterized by richness in adhesion molecules, nonnecessity of additional fixation at an implantation site, and good biological integration.


Patent
Hiroshima University and Q - Cells SE | Date: 2015-10-16

Provided is a differentiation-inducing culture medium additive for inducing bone differentiation of at least one type of cell selected from the group consisting of a stem cell, a dental pulp cell, a periodontal ligament cell, a placenta, an amnion, and a fibroblast under a serum-free condition, and a use of the differentiation-inducing culture medium additive. The differentiation-inducing culture medium additive of the present invention for inducing differentiation of a stem cell under a serum-free condition at least contains at least one growth factor selected from the group consisting of EGF, FGF, and PDGF; dexamethasone; and -glycerophosphate. The differentiation-inducing culture medium additive of the present invention does not require ascorbic acid 2-phosphate and ITS, which are normally essential for bone differentiation. Further, bone differentiation can be promoted by adding phospholipid.

Loading Q - Cells SE collaborators
Loading Q - Cells SE collaborators